Full text is available at the source.
Abstract
Autism spectrum disorder (ASD) is frequently associated with gastrointestinal disturbances and changes in gut microbiota composition.
- Emerging evidence suggests a connection between gut health and the brain in individuals with ASD.
- The microbiota-gut-brain axis may influence the development and symptoms of ASD.
- Interest is growing in therapies targeting the gut microbiome, such as probiotics, prebiotics, synbiotics, and fecal microbiota transplantation.
- Clinical effectiveness and underlying mechanisms of these microbiome-targeted therapies are not fully understood.
- Variability in study designs and outcomes complicates the assessment of these interventions.
Simplified